Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
FTC Sues Pharmacy Middlemen For Allegedly Inflating Insulin Prices
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
FTC sues drug middlemen over manipulating insulin market
The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and ...
The Financial Times34m
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
The Federal Trade Commission has sued America’s largest prescription-drug ... The competition regulator’s complaint names CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum, ...
Anadolu Ajansi57m
US sues 3 health firms for inflating insulin prices, boosting profits at expense of patients
Regulator claims companies rigged pharmaceutical supply chain competition in their favor, forced patients to pay more for ...
FTC sues prescription drug middlemen, alleging they conspired over high insulin costs
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...